Other languages Protagenic Therapeutics, Inc.

Equities

PTIX

US74365N2027

Market Closed - Nasdaq Other stock markets 02:00:00 29/06/2024 am IST			5-day change	1st Jan Change
0.905 ^USD	+0.56%		-9.50%	-8.59%

15/05	Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/05	Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial	01/05
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders	27/03
Protagenic Therapeutics Achieves First Clinical Safety Milestone with Its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders	13/02
Wall Street Set to Open Slightly Higher Tuesday; Annual Inflation Declines to 3.1%	12/12
Protagonist Therapeutics, Inc. Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals	12/12
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01
Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director	29/22/29
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	08/22/08
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	17/21/17
Protagenic Therapeutics : Expects to Refile New Drug Application in Q4 After Implementing Change Requested by FDA	24/21/24
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	18/21/18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Protagenic Therapeutics, Inc.

Equities

PTIX

US74365N2027

Other languages

Filters